Liver Micro Flow - MRI

This study integrates and evaluates a series of novel MRI methods for quantifying blood perfusion and tissue microstructure. The proposed perfusion and microstructure measures may provide biomarkers for fibrosis, cirrhosis, portal hypertension, and response to treatment. The precision of these methods will be evaluated in 110 participants, including healthy volunteers, people with chronic liver disease (CLD), and people with liver fibrosis.

NCT Number	NCT07634939
Lead Sponsor	University of Wisconsin, Madison Collaborators: National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Conditions	Liver Diseases
Enrollment	110 participants
Start Date	2026-07-01
Primary Completion	2029-05 (estimated)
Study Completion	2029-05 (estimated)
Updated on ClinicalTrials.gov	2026-06-10